WWHS Concluded 17th International IVD & Blood Transfusion Expo
On August 21, 2020, WWHS Biotech showcased six world-first infrared fluorescence POCT products at the 17th International Congress on Clinical Laboratory and Transfusion Medicine (CACLP), held at Nanchang Greenland International Expo Center. This annual IVD event attracted over a thousand companies from across the entire upstream, midstream, and downstream industry chain of in vitro diagnostics from home and abroad, with companies from multiple countries and regions showcasing new technologies and equipment in the IVD industry.
During the event, the WWHS Biotech booth received continuous visitors. The WWHS team provided comprehensive introductions to attendees covering product parameters, structure, and application scenarios, and answered questions from visiting clients in real time. The end-to-end solution from product to service received recognition from many users. In the ever-changing post-pandemic era, WWHS Biotech's core technologies and products attracted attention from professionals and manufacturers from around the world.
Shenzhen WWHS Biotech Co., Ltd. is a high-tech enterprise incubated by the Shenzhen Tsinghua University Research Institute, located in the Pingshan District Biomedical Innovation Industrial Park of the Shenzhen National Biotech Industry Base. Leveraging the industrial core of the national biomedical industry base, the company leverages world-class core technology and advanced R&D capabilities to enhance the international competitiveness of China's medical device industry. The R&D team's expertise in biochip development, nanomaterial preparation, and nanobiotechnology is at an internationally leading level. WWHS Biotech is dedicated to developing innovative detection platforms that combine infrared fluorescence enhancement technology with nanobiotechnology. The company's world-first infrared fluorescence POCT technology addresses the core technical challenges of low sensitivity and poor precision associated with traditional POCT, enabling non-invasive and minimally invasive precise detection of in vitro diagnostic reagent products — an international innovation.
